PTPRC and colitis: The number of EGFP+CD45+CD11b+Col I+ fibrocytes in the colonic LP of chronically treated EGFP BM chimeras significantly increased in association with the development of colon inflammation and were markedly reduced 2 months after cessation of DSS treatment (chronic phase).